BR9804582A - Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos. - Google Patents

Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos.

Info

Publication number
BR9804582A
BR9804582A BR9804582-2A BR9804582A BR9804582A BR 9804582 A BR9804582 A BR 9804582A BR 9804582 A BR9804582 A BR 9804582A BR 9804582 A BR9804582 A BR 9804582A
Authority
BR
Brazil
Prior art keywords
compounds
well
benzoazepinone
processes
preparation
Prior art date
Application number
BR9804582-2A
Other languages
English (en)
Inventor
Harald Waldeck
Joerg Meil
Dirk Thormaehlen
Michael Wurl
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR9804582A publication Critical patent/BR9804582A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção:<B>"DERIVADOS DE áCIDO BENZOAZEPINONA-N-ACéTICO SUBSTITUìDOS POR áCIDOS FOSFÈNICOS, ASSIM COMO PROCESSOS PARA A SUA PREPARAçãO E MEDICAMENTOS QUE CONTêM ESTES COMPOSTOS"<D>. São descritos compostos eficazes como inibidores da endopeptidase neutral (NEP), de fórmula geral I na qual R^ 1^ representa hidrogênio ou um grupo que forme um fosfonato biologicamente instável, R^ 2^representa hidrogênio ou um grupo que forme um fosfonato biologicamente instável, R^ 3^ representa hidrogênio ou um grupo que forme um carbonato biologicamente instável, e os sais fisiologicamente aceitáveis dos ácidos de fórmula I, assim como medicamentos que contêm estes compostos.
BR9804582-2A 1997-11-12 1998-11-11 Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos. BR9804582A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19750002A DE19750002A1 (de) 1997-11-12 1997-11-12 Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
BR9804582A true BR9804582A (pt) 2000-05-09

Family

ID=7848410

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9804582-2A BR9804582A (pt) 1997-11-12 1998-11-11 Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos.

Country Status (28)

Country Link
US (1) US5952327A (pt)
EP (1) EP0916679B1 (pt)
JP (1) JP4162780B2 (pt)
KR (1) KR19990045100A (pt)
CN (1) CN1187361C (pt)
AR (1) AR009911A1 (pt)
AT (1) ATE228144T1 (pt)
AU (1) AU746907B2 (pt)
BR (1) BR9804582A (pt)
CA (1) CA2253997C (pt)
CZ (1) CZ296123B6 (pt)
DE (2) DE19750002A1 (pt)
DK (1) DK0916679T3 (pt)
DZ (1) DZ2652A1 (pt)
ES (1) ES2186961T3 (pt)
HK (1) HK1019338A1 (pt)
HU (1) HU221177B1 (pt)
ID (1) ID21393A (pt)
IL (1) IL126984A (pt)
NO (1) NO317640B1 (pt)
NZ (1) NZ332744A (pt)
PL (1) PL191436B1 (pt)
PT (1) PT916679E (pt)
RU (1) RU2211219C2 (pt)
SK (1) SK283233B6 (pt)
TR (1) TR199802289A3 (pt)
UA (1) UA60304C2 (pt)
ZA (1) ZA9810316B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20033183A3 (cs) * 2001-05-18 2004-07-14 Solvay Pharmaceuticals Gmbh Použití sloučenin s kombinovanou inhibiční aktivitou NEP/ MP v přípravě léčiv
RU2303041C2 (ru) * 2002-01-16 2007-07-20 Солвей Фармасьютикалс Б.В. Твердые соли бензазепиновых соединений и их применение при получении фармацевтических соединений
CL2004000544A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) * 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
CA2551789C (en) * 2004-01-12 2011-05-03 Solvay Pharmaceuticals B.V. Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders
US7232813B2 (en) * 2004-01-12 2007-06-19 Solvay Pharmaceuticals B.V. Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
CA2590278A1 (en) 2004-12-15 2006-06-22 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US8198341B2 (en) 2008-12-18 2012-06-12 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
CN107383093B (zh) 2012-10-17 2021-07-16 Icl-Ip美国有限公司 羟甲基膦酸酯、组合物、聚氨酯泡沫及制品
US9528269B2 (en) 2014-06-09 2016-12-27 Johns Manville Roofing systems and roofing boards with non-halogenated fire retardant
US9523195B2 (en) 2014-06-09 2016-12-20 Johns Manville Wall insulation boards with non-halogenated fire retardant and insulated wall systems
US9815256B2 (en) 2014-06-09 2017-11-14 Johns Manville Foam boards including non-halogenated fire retardants
US9815966B2 (en) 2014-07-18 2017-11-14 Johns Manville Spray foams containing non-halogenated fire retardants
CN107383084A (zh) * 2017-06-14 2017-11-24 浙江嘉华化工有限公司 一种0‑乙基磷酸钠的制备方法
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
PL424453A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors

Also Published As

Publication number Publication date
PT916679E (pt) 2003-03-31
DK0916679T3 (da) 2002-12-16
ID21393A (id) 1999-06-03
DE59806345D1 (de) 2003-01-02
DZ2652A1 (fr) 2003-03-15
NO317640B1 (no) 2004-11-29
JP4162780B2 (ja) 2008-10-08
HK1019338A1 (en) 2000-02-03
SK283233B6 (sk) 2003-04-01
ATE228144T1 (de) 2002-12-15
ZA9810316B (en) 1999-05-18
CZ296123B6 (cs) 2006-01-11
SK151698A3 (en) 1999-05-07
IL126984A (en) 2001-07-24
PL191436B1 (pl) 2006-05-31
HUP9802517A2 (hu) 1999-09-28
HU221177B1 (en) 2002-08-28
UA60304C2 (uk) 2003-10-15
RU2211219C2 (ru) 2003-08-27
CN1217334A (zh) 1999-05-26
EP0916679B1 (de) 2002-11-20
TR199802289A2 (xx) 1999-06-21
CA2253997C (en) 2009-05-12
AU9234498A (en) 2000-06-08
AU746907B2 (en) 2002-05-02
NO985262L (no) 1999-05-14
DE19750002A1 (de) 1999-05-20
IL126984A0 (en) 1999-09-22
ES2186961T3 (es) 2003-05-16
CZ356298A3 (cs) 1999-06-16
PL329635A1 (en) 1999-05-24
HUP9802517A3 (en) 2000-06-28
US5952327A (en) 1999-09-14
CN1187361C (zh) 2005-02-02
HU9802517D0 (en) 1998-12-28
EP0916679A1 (de) 1999-05-19
KR19990045100A (ko) 1999-06-25
NZ332744A (en) 2000-06-23
AR009911A1 (es) 2000-05-03
CA2253997A1 (en) 1999-05-12
TR199802289A3 (tr) 1999-06-21
JPH11292886A (ja) 1999-10-26
NO985262D0 (no) 1998-11-11

Similar Documents

Publication Publication Date Title
BR9804582A (pt) Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos.
BR9912188A (pt) Derivados de 1,1-dióxido de benzo (b) tiepina, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
BR9915967A (pt) Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR0116482A (pt) Derivados de difenilazetidinona, processo para a preparação, medicamentos contendo esses compostos e seu emprego.
BR0111457A (pt) Derivados de acilfeniluréia, processos para a sua preparação e sua aplicação como medicamentos
BR0210285A (pt) Utilização de um composto, composto e composição farmacêutica
TR199500825A2 (tr) Cok üniteli farmasötik müstahzar.
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9912921A (pt) Processos para a preparação de n- (fosfonometil) glicina, de um sal de n- (fosfonometil) glicina, ou de um éster de n- (fosfonometil) glicina, para a preparação de uma n- (fosfonometil) glicina substituìda em n ou um seu sal, e para a preparação de uma monoetanolamina substituìda em n, e, catalisador de oxidação
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
BR9908458A (pt) Tiolésteres de ácido 11beta-benzaldoxim-estra-4,9-dien-carbÈnico substituìdos por s, processos para a sua preparação e preparados farmacêuticos contendo estes compostos
BR0110357A (pt) Sais bicìclicos e n-aciclados de aminas imidazo - 3 e imidazo -5
BR9914266A (pt) Derivados de propanolamina substituìdos por heterociclos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego
PT1051159E (pt) Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
BR9712707A (pt) Derivados de ácido 4-bifenil-4-hidroxibutìrico substituìdo com inibidores de metaloprotease de matriz
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas
DK440888D0 (da) Hjaelpestoffer som resorptionsfremmende stoffer af peptider og proteiner ved paafoering paa slimhinder samt anvendelse deraf g praepparat indeholdende hjaelpestofferne
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
BR9800763A (pt) Novos compostos 2-amino indano, um processo para sua preparação e composições farmacêuticas contendo os mesmos.
PT84680B (pt) Processo para a preparacao de derivados de 1,5-benzotiazepina e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/11/1998, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 14A ANUIDADE, CONFORME ART. 87 DA LPI 9.279.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.